Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Conditions: HIV-1-infection Interventions: Biological: ChAdOx1.tHIVconsv1; Biological: ChAdOx1.HIVconsv62; Biological: MVA.tHIVconsv3; Biological: MVA.tHIVconsv4; Drug: Vesatolimod (VES); Drug: GS-5423; Drug: GS-2872; Biological: MVA.tHIVconsv4; Biological: Placebo Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Oxford; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials

Assessment of the Applicability and Acceptability of an Algorithm to Guide the Prescription of 1st and 2nd Generation Cephalosporins as Part of Intraoperative Antibiotic Prophylaxis in Patients With a Declared Allergy to Penicillin
Conditions: Adult Patients Who Declare an Allergy to Penicillin During Anaesthetic Consultation Without Any Allergy Work up That Could Confirm This Declaration; Good Comprehension of French Language Interventions: Other: decision tree for the choice of intraoperative antibiotic prophylaxis Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials

Double Blind Placebo-controlled Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms of Allergic Rhinitis in Response to Cat Dander Challenge
Conditions: Allergy to Cats Interventions: Drug: Zafirlukast Sponsors: Allergy& Asthma Medical Group& Research Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials

Randomized Controlled Trial for Wheat Oral Immunotherapy
Conditions: Allergy;Food; Wheat Allergy; Children Interventions: Other: Wheat-containing food Sponsors: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials

Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children
Conditions: Rhinitis, Allergic; Asthma, Allergic; Conjunctivitis, Allergic; Atopic Dermatitis; Chronic Urticaria Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials

Patient Portal Flu Vaccine Reminders (RCT 6)
Conditions: Influenza; Respiratory Tract Infections Interventions: Behavioral: Portal-based Video Message; Behavioral: Portal-based Infographic Message Sponsors: University of California, Los Angeles; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials

Foam Tape Allergy a Sticky Situation
Conditions:   Medical Adhesive Allergy;   Dermatologic Conditions;   Dermatologic Lesions Intervention:   Other: 2x2 inch piece of 3M microfoam adhesive Sponsor:   CHRISTUS Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Foam Tape Allergy a Sticky Situation
Conditions: Medical Adhesive Allergy; Dermatologic Conditions; Dermatologic Lesions Interventions: Other: 2x2 inch piece of 3M microfoam adhesive Sponsors: CHRISTUS Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Advancing Transplantation Outcomes in Children
Condition:   Kidney Transplant Interventions:   Drug: Sirolimus;   Biological: Belatacept;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus (Group1);   Drug: Anti-Thymocyte Globulin (ATG);   Drug: Tacrolimus (Group 2) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Conditions:   Kidney Transplant;   Kidney Failure;   Highly Sensitized Interventions:   Drug: Cyclophosphamide;   Biological: CART-BCMA;   Biological: huCART19;   Drug: Fludarabine Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Advancing Transplantation Outcomes in Children
Conditions: Kidney Transplant Interventions: Drug: Sirolimus; Biological: Belatacept; Drug: Mycophenolate Mofetil; Drug: Tacrolimus (Group1); Drug: Anti-Thymocyte Globulin (ATG); Drug: Tacrolimus (Group 2) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Conditions: Kidney Transplant; Kidney Failure; Highly Sensitized Interventions: Drug: Cyclophosphamide; Biological: CART-BCMA; Biological: huCART19; Drug: Fludarabine Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Contact Allergy to Rubber Accelerators - a Clinical Study
Condition:   Contact Allergy Interventions:   Other: Rubber accelerators and control chamber/solution for NON-SLS group;   Other: SLS;   Other: Rubber accelerators and control chamber/solution for SLS group;   Other: Patch test on back Sponsor:   National Allergy Research Center, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials